Evolus (EOLS) Exchange Rate Effect (2022 - 2026)
Evolus (EOLS) posted Exchange Rate Effect of -$10000.0 for Q1 2026, up 97.7% on a QoQ basis from -$435000.0 in Q4 2025, and down 115.15% year-over-year from $66000.0 in Q1 2025.
Evolus (EOLS) Exchange Rate Effect (2022 - 2026) Analysis & Trends
Evolus' Exchange Rate Effect history runs 5 years deep, the most recent figure standing at -$10000.0 for Q1 2026.
- Quarterly Exchange Rate Effect fell 115.15% year-over-year to -$10000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $178000.0 (up 163.12% YoY) and the FY2025 annual result came in at $254000.0, up 153.14% from the prior year.
- Exchange Rate Effect was -$10000.0 for Q1 2026 at Evolus, up from -$435000.0 in the prior quarter.
- Across five years, Exchange Rate Effect topped out at $384000.0 in Q3 2025 and bottomed at -$435000.0 in Q4 2025.
- A 5-year average of -$38882.4 and a median of -$62000.0 in 2022 frame the typical range for Exchange Rate Effect.
- Annual changes were most pronounced in 2024 — Exchange Rate Effect plunged 220.67% — and 2025, when it surged 643.18%.
- Evolus' Exchange Rate Effect stood at $31000.0 in 2022, then soared by 477.42% to $179000.0 in 2023, then plunged by 220.67% to -$216000.0 in 2024, then tumbled by 101.39% to -$435000.0 in 2025, then jumped by 97.7% to -$10000.0 in 2026.
- Business Quant data shows EOLS's Exchange Rate Effect at -$10000.0 in Q1 2026, -$435000.0 in Q4 2025, and $384000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -17.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 17.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 7.01 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -4.20 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -5.00 Mn |
| 10 | Evolus | 390.47 Mn | 340.68 Mn | 48.90 Mn | -10,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -10,000.00 |
| Mar 31, 2026 | -10,000.00 |
| Dec 31, 2025 | -435,000.00 |
| Dec 31, 2025 | -435,000.00 |
| Sep 30, 2025 | 384,000.00 |
| Sep 30, 2025 | 384,000.00 |
| Jun 30, 2025 | 239,000.00 |
| Jun 30, 2025 | 239,000.00 |
| Mar 31, 2025 | 66,000.00 |
| Mar 31, 2025 | 66,000.00 |
| Dec 31, 2024 | -216,000.00 |
| Dec 31, 2024 | -216,000.00 |
| Sep 30, 2024 | -88,000.00 |
| Sep 30, 2024 | -88,000.00 |
| Jun 30, 2024 | -44,000.00 |
| Jun 30, 2024 | -44,000.00 |
| Mar 31, 2024 | -130,000.00 |
| Mar 31, 2024 | -130,000.00 |
| Dec 31, 2023 | 179,000.00 |
| Dec 31, 2023 | 179,000.00 |